Business Description
Vyant Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US92942V2088
Description
Vyant Bio Inc incorporates biology and data science to improve drug discovery for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. The company's platform is designed to: 1) elucidate disease pathophysiology; 2) formulate key therapeutic hypotheses; 3) identify and validate drug targets, cellular assays, and biomarkers to guide candidate molecule selection; and 4) guide clinical trial patient selection and trial design. The majority of revenue is earned in the United States.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 22.3 | |||||
| 14-Day RSI | 27.21 | |||||
| 6-1 Month Momentum % | -17.2 | |||||
| 12-1 Month Momentum % | -74.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -2153.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-Revenue | 22.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vyant Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.628 | ||
| EPS (TTM) (€) | -3.675 | ||
| Beta | 0 | ||
| Volatility % | 61.52 | ||
| 14-Day RSI | 27.21 | ||
| 14-Day ATR (€) | 0.00003 | ||
| 20-Day SMA (€) | 0.13 | ||
| 12-1 Month Momentum % | -74.51 | ||
| 52-Week Range (€) | 0.13 - 0.53 | ||
| Shares Outstanding (Mil) | 6.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vyant Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vyant Bio Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vyant Bio Inc Frequently Asked Questions
What is Vyant Bio Inc(STU:1C80)'s stock price today?
The current price of STU:1C80 is €0.13. The 52 week high of STU:1C80 is €0.53 and 52 week low is €0.13.
When is next earnings date of Vyant Bio Inc(STU:1C80)?
The next earnings date of Vyant Bio Inc(STU:1C80) is 2024-08-15 Est..
Does Vyant Bio Inc(STU:1C80) pay dividends? If so, how much?
Vyant Bio Inc(STU:1C80) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers